A phase I study assessing HM-04 for the treatment of Prader-Willi syndrome
Latest Information Update: 31 Jul 2020
At a glance
- Drugs HM-04 (Primary)
- Indications Prader-Willi syndrome
- Focus Adverse reactions
- Sponsors Helsinn
- 31 Jul 2020 New trial record